Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10).

Autor: Okuda R; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ochi Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. ochi.yotaro.24v@kyoto-u.jp., Saiki R; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yamanaka T; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Terao C; Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Clinical Research Center, Shizuoka General Hospital, Shizuoka, Japan.; The Department of Applied Genetics, The School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan., Yoshizato T; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Nakagawa MM; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Zhao L; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ohyashiki K; Department of Hematology, Tokyo Medical University, Tokyo, Japan., Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Hyogo, Japan., Sanada M; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Advanced Diagnosis, Clinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan., Handa H; Department of Hematology, Graduate School of Medicine, Gunma University, Gunma, Japan., Kasahara S; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Miyazaki Y; Japan Adult Leukemia Study Group, and Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Sezaki N; Department of Hematology, Chugoku Central Hospital, Hiroshima, Japan., Shih LY; Division of Hematology-Oncology, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan, Taiwan., Kern W; MLL Munich Leukemia Laboratory, Munich, Germany., Kanemura N; Department of Hematology and Infectious Disease, Gifu University Graduate School of Medicine, Gifu, Japan., Kitano T; Department of Hematology, Tazuke Kofukai, Medical Research Institute, Kitano Hospital, Osaka, Japan., Imashuku S; Department of Laboratory Medicine, Uji-Tokushukai Medical Center, Uji, Japan., Watanabe M; Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan., Creignou M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Center for Clinical Cancer Studies, Phase 1 Unit, Karolinska University Hospital, Stockholm, Sweden., Chonabayashi K; Department of Cell Growth and Differentiation, Center for iPS Research and Application, Kyoto University, Kyoto, Japan.; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan., Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Hyogo, Japan., Gotoh A; Department of Hematology, Tokyo Medical University, Tokyo, Japan., Atsuta Y; The Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Aichi, Japan., Shiraishi Y; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Mitani K; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan., Chiba S; Department of Hematology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan., Takaori-Kondo A; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Miyano S; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan., Kamatani Y; Department of Computational Biology and Medical Sciences, Graduate Schools of Frontier Sciences, The University of Tokyo, Tokyo, Japan., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Hellström-Lindberg E; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Matsuda K; Department of Computational Biology and Medical Sciences, Graduate Schools of Frontier Sciences, The University of Tokyo, Tokyo, Japan., Yoshida Y; Department of Cell Growth and Differentiation, Center for iPS Research and Application, Kyoto University, Kyoto, Japan., Makishima H; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Nannya Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ogawa S; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. sogawa-tky@umin.ac.jp.; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan. sogawa-tky@umin.ac.jp.

Publikováno v: Leukemia [Leukemia] 2024 Dec 23. Date of Electronic Publication: 2024 Dec 23.

Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.

Autor: Yokota H; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Miyao K; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Terakura S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Kurahashi S; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan., Ikoma Y; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Imahashi N; Department of Hematology, NHO Nagoya Medical Center, Nagoya, Japan., Morishita T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan., Okamoto A; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan., Kajiguchi T; Department of Hematology and Oncology, Tosei General Hospital, Seto, Japan., Ono T; Department of Internal Medicine, School of Medicine, Hamamatsu University, Hamamatsu, Japan., Narita T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Kanemura N; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Ozeki K; Department of Hematology and Oncology, Konan Kosei Hospital, Konan, Japan., Kojima Y; Department of Hematology, Nagoya Ekisaikai Hospital, Nagoya, Japan., Naito K; Department of Hematology, Hamamatsu Medical Center, Hamamatsu, Japan., Uchino K; Department of Internal Medicine, Division of Hematology, Aichi Medical University School of Medicine, Nagakute, Japan., Tomita A; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan., Iida H; Department of Hematology, NHO Nagoya Medical Center, Nagoya, Japan., Imoto N; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan., Kasahara S; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Inagaki Y; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Nishida T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan., Murata M; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Publikováno v: Journal of hematology [J Hematol] 2024 Aug; Vol. 13 (4), pp. 142-149. Date of Electronic Publication: 2024 Aug 10.

Comparison of 19-gauge conventional and Franseen needles for the diagnosis of lymphadenopathy and classification of malignant lymphoma using endoscopic ultrasound fine-needle aspiration.

Autor: Okuno M; Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan., Iwata K; Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan., Mukai T; Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan.; Department of Gastroenterological Endoscopy, Kanazawa Medical University, Ishikawa, Japan., Kito Y; Department of Pathology and Translational Research, Gifu University Graduate School of Medicine, Gifu, Japan., Tanaka T; Department of Diagnostic Pathology, Gifu Municipal Hospital, Gifu, Japan., Watanabe N; Department of Diagnostic Pathology, Gifu Municipal Hospital, Gifu, Japan., Kasahara S; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Iwasa Y; Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan., Sugiyama A; Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan., Nishigaki Y; Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan., Shibata Y; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Kitagawa J; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Iwashita T; First Department of Internal Medicine, Gifu Univeristy Hospital, Gifu, Japan., Tomita E; Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan., Shimizu M; First Department of Internal Medicine, Gifu Univeristy Hospital, Gifu, Japan.

Publikováno v: Clinical endoscopy [Clin Endosc] 2024 May; Vol. 57 (3), pp. 364-374. Date of Electronic Publication: 2023 Sep 08.

The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma.

Autor: Kaneda Y; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Kanemura N; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Nakamura N; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Ikoma Y; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Yamaguchi K; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Takada E; Department of Hematology, Gifu-Seino Medical Center, Gihoku Kosei Hospital, Gifu, Japan., Shibata Y; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Lee S; Department of Hematology, Matsunami General Hospital, Gifu, Japan., Fujita K; Department of Hematology, Matsunami General Hospital, Gifu, Japan., Morishita T; Department of Hematology, Matsunami General Hospital, Gifu, Japan., Matsumoto T; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Nakamura H; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Kitagawa J; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Kasahara S; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Hara T; Department of Hematology, Matsunami General Hospital, Gifu, Japan., Tsurumi H; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.; Department of Hematology, Matsunami General Hospital, Gifu, Japan., Shimizu M; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Mar; Vol. 65 (3), pp. 339-345. Date of Electronic Publication: 2023 Dec 20.

A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non-Hodgkin lymphoma.

Autor: Ikoma Y; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Nakamura N; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Kitagawa J; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Miwa T; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Takada E; Department of Hematology, Gifu-Seino Medical Center, Gihoku Kosei Hospital, Gifu, Japan., Matsumoto T; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Shibata Y; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Nakamura H; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Kanemura N; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.; Department of Hematology, Chuno Kosei Hospital, Gifu, Japan., Kasahara S; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.; Laboratory of Pharmaceutical Health Care and Promotion, Gifu Pharmaceutical University, Gifu, Japan., Hara T; Department of Hematology, Matsunami General Hospital, Gifu, Japan., Sawada M; Department of Hematology, Gifu Red Cross Hospital, Gifu, Japan., Tsurumi H; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.; Department of Hematology, Matsunami General Hospital, Gifu, Japan., Shimizu M; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.

Publikováno v: Hematological oncology [Hematol Oncol] 2024 Jan; Vol. 42 (1), pp. e3236. Date of Electronic Publication: 2023 Nov 06.